ArticleClinical pharmacokinetics2014
Pharmacokinetic and pharmacodynamic profile of empagliflozin, a sodium glucose co-transporter 2 inhibitor.
André J ScheenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
120 papers cite itlatest 60 shown
this paperpooled ittrialcites it